Lithium Ion

Lithium Ion

SCHEMBL2400971

Cn1cccc1/C=C/c1ccc(C(=O)[O-])cc1.[Li+]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.43
TRIM33 Q9UPN9 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
NFKB1 P19838 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
TLR9 Q9NR96 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2399252 0.84 EP300 (0.48) TRIM24TRIM33SMN1; SMN2MEN1KMT2A
SCHEMBL2399255 0.84 EP300 (0.48) TRIM24TRIM33SMN1; SMN2MEN1KMT2A
SCHEMBL2400966 0.83 EP300 (0.47) TRIM24TRIM33SMN1; SMN2MEN1KMT2A
SCHEMBL2400973 0.83 EP300 (0.47) TRIM24TRIM33SMN1; SMN2MEN1KMT2A
SCHEMBL2399810 0.81 PTPN1 (0.52) TRIM24TRIM33SMN1; SMN2MEN1KMT2A
SCHEMBL2399812 0.81 PTPN1 (0.52) TRIM24TRIM33SMN1; SMN2MEN1KMT2A
SCHEMBL2787808 0.75 TRIM24 (0.52) TRIM24TRIM33SMN1; SMN2MEN1KMT2A
SCHEMBL2787807 0.75 TRIM24 (0.52) TRIM24TRIM33SMN1; SMN2MEN1KMT2A
SCHEMBL12086582 0.75 TRIM24 (0.52) TRIM24TRIM33SMN1; SMN2MEN1KMT2A
Potassium Ion SCHEMBL11837959 0.74 CA2 (0.52) ALDH1A1HPGDHDAC1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012967-B2 Minor groove binders UNIVERSITY OF STRATHCLYDE (GB) 2011-09-06 US disclosed
US-20100016311-A1 NOVEL MINOR GROOVE BINDERS UNIVERSITY OF STRATHCLYDE (GB) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016311-A1 NOVEL MINOR GROOVE BINDERS TOP2B, DNA2, CTCF TRIM24 1532/4885TRIM33 2353/4885SMN1; SMN2 4129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.